Revolutionizing Chronic Kidney Disease Treatment
We are an innovative biotech company dedicated to advancing breakthrough cell therapy for Chronic Kidney Disease (CKD). Our cutting-edge treatment aims to slow disease progression and preserve kidney function, offering hope to patients with limited options beyond dialysis. Committed to transforming kidney care, we strive to redefine the future of CKD management with science-driven solutions.
Our Mission
Kidney Pro India is a pioneer in Chronic Kidney Disease (CKD) treatment. While existing treatments can slow CKD progression to End-Stage Kidney Disease (ESKD), there is no cure. At Kidney Pro India, we are at the forefront of cellular therapy, focusing on preserving kidney function and potentially delaying or eliminating the need for dialysis..
The Need for Advanced CKD Treatment
Chronic Kidney Disease (CKD) is a significant health concern in India, affecting approximately 17.2% of the adult population. Each year, over 100,000 new patients require renal replacement therapy, including dialysis. While current treatments may slow CKD progression, many patients continue to experience declining kidney function, leading to End-Stage Kidney Disease (ESKD). Management of Stage 4 CKD often focuses on addressing associated health issues and preparing for dialysis, underscoring the urgent need for innovative therapeutic solutions.
Rilparencel – A Breakthrough in Kidney Care
Formerly known as REACT®, Rilparencel is an advanced cell therapy candidate that shows promising potential in preserving kidney function. Early clinical data suggest that it may help delay or even eliminate the need for dialysis, offering new hope for patients with Chronic Kidney Disease (CKD).